HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Charles Fruchart Selected Research

Jean-Charles Fruchart Research Topics

Disease

36Atherosclerosis
01/2019 - 05/2002
22Type 2 Diabetes Mellitus (MODY)
01/2020 - 05/2004
20Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 05/2003
18Coronary Disease (Coronary Heart Disease)
09/2007 - 07/2002
15Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 08/2004
15Dyslipidemias (Dyslipidemia)
01/2020 - 08/2003
14Inflammation (Inflammations)
01/2020 - 01/2002
10Insulin Resistance
08/2007 - 08/2003
9Hypertriglyceridemia
12/2018 - 12/2002
7Myocardial Infarction
09/2007 - 09/2002
6Obesity
05/2013 - 08/2005
6Stroke (Strokes)
09/2007 - 07/2003
5Hypertension (High Blood Pressure)
05/2007 - 08/2002
4Hepatocellular Carcinoma (Hepatoma)
11/2004 - 12/2002
3Heart Failure
12/2018 - 06/2007
3Hyperlipidemias (Hyperlipidemia)
08/2007 - 08/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
05/2006 - 12/2002
3Atherosclerotic Plaque (Atheroma)
01/2006 - 03/2004
3Hepatoblastoma
08/2003 - 04/2002
2Alcoholic Fatty Liver
01/2022 - 01/2020
2Chronic Renal Insufficiency
01/2020 - 04/2006
2Thrombosis (Thrombus)
12/2018 - 02/2007
2Acute Coronary Syndrome
01/2011 - 04/2005
2Heart Arrest (Cardiac Arrest)
09/2007 - 04/2005
2Angina Pectoris
09/2003 - 08/2002
1Non-alcoholic Fatty Liver Disease
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Diabetic Retinopathy (Retinopathy, Diabetic)
12/2018
1Peripheral Arterial Disease
12/2018
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Abdominal Obesity
10/2009
1Systemic Vasculitis
12/2007
1Pathologic Complete Response
12/2007
1Muscular Diseases (Myopathy)
08/2007
1Rhabdomyolysis
08/2007

Drug/Important Bio-Agent (IBA)

29LipidsIBA
01/2020 - 01/2002
27Triglycerides (Triacylglycerol)IBA
01/2021 - 08/2002
23PPAR alphaIBA
01/2021 - 09/2002
18HDL CholesterolIBA
01/2021 - 07/2002
17LDL CholesterolIBA
01/2020 - 08/2002
16Lipoproteins (Lipoprotein)IBA
12/2019 - 06/2002
15Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2007 - 01/2002
14oxidized low density lipoproteinIBA
12/2018 - 05/2002
14Glucose (Dextrose)FDA LinkGeneric
10/2009 - 09/2002
12LigandsIBA
08/2008 - 12/2002
11CholesterolIBA
08/2008 - 09/2002
10ApolipoproteinsIBA
11/2008 - 07/2003
9Fibric Acids (Fibrates)IBA
05/2013 - 12/2002
9LDL Lipoproteins (beta Lipoproteins)IBA
11/2008 - 08/2002
7Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2017 - 04/2004
7Fenofibrate (CiL)FDA LinkGeneric
01/2016 - 12/2002
7PPAR gammaIBA
08/2007 - 09/2003
6(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
01/2022 - 10/2017
6Apolipoprotein A-I (Apolipoprotein A1)IBA
12/2007 - 04/2002
6ThiazolidinedionesIBA
08/2007 - 08/2003
6Messenger RNA (mRNA)IBA
06/2007 - 02/2003
5Insulin (Novolin)FDA Link
01/2019 - 05/2004
5HDL LipoproteinsIBA
11/2008 - 07/2002
5Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
07/2007 - 09/2003
4Atorvastatin (Lipitor)FDA Link
11/2006 - 04/2005
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2020 - 07/2003
3Biomarkers (Surrogate Marker)IBA
12/2018 - 06/2004
3Apolipoproteins E (ApoE)IBA
04/2009 - 06/2005
3Apolipoprotein A-VIBA
08/2008 - 01/2007
3Liver X ReceptorsIBA
08/2008 - 04/2003
3C-Reactive ProteinIBA
12/2007 - 07/2003
3Trinitrotoluene (TNT)IBA
11/2006 - 06/2006
3Interleukin-6 (Interleukin 6)IBA
05/2006 - 07/2003
3GW 4064IBA
04/2006 - 02/2003
3AntioxidantsIBA
05/2005 - 07/2003
3Chenodeoxycholic Acid (Chenix)FDA Link
11/2004 - 02/2003
2Apolipoprotein E2IBA
08/2008 - 12/2006
2Aryldialkylphosphatase (Paraoxonase)IBA
12/2007 - 05/2004
2HomocysteineIBA
08/2007 - 06/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2007 - 05/2006
2Proteins (Proteins, Gene)FDA Link
05/2007 - 06/2003
2Fibrinogen (Factor I)FDA Link
05/2006 - 07/2003
2Gemfibrozil (Lopid)FDA LinkGeneric
01/2006 - 12/2002
2MelatoninIBA
09/2005 - 05/2002
2Transcription Factors (Transcription Factor)IBA
08/2005 - 09/2002
2IDL Lipoproteins (Lipoprotein, IDL)IBA
06/2005 - 06/2004
2VLDL LipoproteinsIBA
06/2005 - 06/2004
2PolyphenolsIBA
12/2004 - 03/2003
2Lipoprotein(a)IBA
06/2004 - 08/2002
2EnzymesIBA
05/2004 - 07/2003
2Bile Acids and Salts (Bile Acids)IBA
04/2004 - 04/2002
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2003 - 07/2003
16- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
01/2022
1Sodium-Glucose Transport ProteinsIBA
01/2022
1Cell Adhesion MoleculesIBA
01/2020
1Antigen-Antibody Complex (Immune Complex)IBA
12/2007
1Anticardiolipin AntibodiesIBA
12/2007
1AntibodiesIBA
12/2007
1Apolipoproteins AIBA
08/2007
1CreatinineIBA
08/2007

Therapy/Procedure

9Therapeutics
10/2017 - 06/2004
3Secondary Prevention
12/2018 - 12/2002
2Drug Therapy (Chemotherapy)
11/2008 - 06/2004
2Resuscitation
09/2007 - 04/2005
1Aftercare (After-Treatment)
12/2018